Polymorphisms of the CYP450 genes that encode for the
enzymes that metabolize
estrogen are linked to
hormone-related
cancers. We investigated the impact of two polymorphisms of the CYP1B1 gene previously reported to be associated with
hormone-related disorders on
estrogen metabolism and bone mineral density (BMD), another
hormone-dependent condition, in women from different ethnic backgrounds. Four hundred sixty-eight postmenopausal Caucasian women, 220 from St. Louis, MO, USA (mean age=63.5+/-0.53 years) and 248 from Palermo, Italy (mean age=72.9+/-0.44 years) participated in the study. Measurements of urinary
estrogen metabolites by
enzyme-linked immunoassay, serum
estradiol by ultrasensitive radioimmnunoassay, and serum
sex hormone-binding globulin by immunoradiometric assay were performed only in the American women, while BMD by dual energy X-ray absorptiometry and genotyping by pyrosequencing were performed in both American and Italian women. Differences in the levels of metabolites, free
estradiol index and BMD were analyzed by analysis of covariance. Analysis among the American participants for the Valine432Leucine polymorphism showed that, compared to women with the
Val/Val genotype, women with the Leu allele (
Val/Leu and
Leu/Leu) had significantly higher log-transformed values of total urinary
estrogen metabolite (ng/mg-
creatinine) levels (1.23+/-0.04, 1.35+/-0.02, and 1.34+/-0.03; p=0.03), and significantly lower BMD (gm/cm(2)) in the lumbar spine (1.009+/-0.02, 0.955+/-0.01 and 0.931+/-0.02; p=0.03) and the femoral neck (0.748+/-0.02, 0.717+/-0.01 and 0.693+/-001, p=0.03) for the
Val/Val, Val/Leu and
Leu/Leu genotypes respectively. There were no significant differences in the urinary metabolites and BMD in the different genotypes for the Alanine119Serine polymorphism among the American women. Meanwhile, a separate analysis among the Italian women revealed no significant differences in BMD among the different genotypes for the two polymorphisms investigated. In conclusion, women with the Leu allele for the CYP1B1 Val432polymorphism have increased
estrogen catabolism, as indicated by higher urinary
estrogen metabolites, compared to those with
Val/Val genotype. This may lead to relative hypoestrogenism and lower BMD in the lumbar spine and femoral neck in these women. Our data suggest that through its effect on the rate of
estrogen catabolism, the Val432Leu polymorphism of the CYP1B1 gene may represent as a possible genetic risk factor for
osteoporosis in American women.